Mito 40 mg Injection belongs to a group of medicines known as 'anti-cancer' used in cancer therapy. It is most effective in the treatment of advanced metastatic stomach cancer (stomach carcinoma), advanced and/or metastatic breast cancer (breast carcinoma), cancer of the respiratory tract (non-small cell bronchial carcinoma), and advanced cancer of the pancreas (pancreatic carcinoma). Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one body part before spreading to other areas. This process is known as metastasis.

Mito 40 mg Injection contains Mitomycin, an anti-cancer medication that is cytotoxic (causes cell death). It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby stopping cancer cells from dividing. As a result, cancer cell growth and spread stopped or slowed.

Healthcare professionals administer Mito 40 mg Injection. It is intended to be used as an injection or infusion into a blood vessel. Depending upon your medical condition, you are advised to take Mito 40 mg Injection for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects such as nausea, vomiting, hair loss, kidney disorders, fever, and lung disorders. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking Mito 40 mg Injection, inform your doctor if you have any infection because Mito 40 mg Injection may worsen the infection. Some patients may experience increased sensitivity to light while taking Mito 40 mg Injection, and avoiding prolonged exposure to sunlight is recommended. Inform your doctor if you are pregnant as Mito 40 mg Injection can cause harmful effects on the unborn baby. Both women and men using this Mito 40 mg Injection should use birth control to avoid pregnancy. You should not take this Mito 40 mg Injection during breastfeeding. Inform your doctor if you take Mito 40 mg Injection. Use the Mito 40 mg Injection with caution in elderly patients. Do not take live vaccines three months after your last chemotherapy. Before starting therapy, your doctor may recommend you undergo tests for lung, kidney, and liver function to exclude any diseases.

Mito 40 mg Injection belongs to the group of anti-cancer medicines containing Mitomycin. It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby destroying quickly dividing cells. As a result, the growth and spread of cancer cells in stopped or slowed down.

Before taking the Mito 40 mg Injection, inform your doctor if you have any active infection. Some patients may experience increased sensitivity to light while taking Mito 40 mg Injection and avoiding prolonged exposure to sunlight is recommended. Consult your doctor if you are pregnant as Mito 40 mg Injection can cause harmful effects on the unborn baby. Both women and men using this Mito 40 mg Injection should use birth control to avoid pregnancy. You should not take Mito 40 mg Injection during breastfeeding. Use the Mito 40 mg Injection with caution in elderly patients. Inform your doctor if you have impaired lung, kidney, or liver function, urinary bladder inflammation, or are undergoing radiation therapy. Mito 40 mg Injection is not recommended for use in children and adolescents.

• Eat a healthy diet and exercise regularly to maintain proper weight.
• Avoid smoking and alcohol consumption.
• Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs in your dialy diet.
• Avoid fast, fried, processed meats, refined carbs, and added sugars.
• Get optimal sleep, and rest well.

• Regularly monitor your blood tests to monitor your liver function, electrolyte levels, and blood cell count in your blood.
• Avoid unnecessary or prolonged exposure to sunlight and UV light (such as tanning booths) and wear protective clothing, sunglasses, and sunscreen. Mito 40 mg Injection may make your skin sensitive to sunlight.
• Mito 40 mg Injection should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Mito 40 mg Injection.
• Consult a doctor immediately if you notice any signs of infection, fever, diarrhoea, chills, etc.

Breast cancer: Breast cancer is a type of cancer that develops in breast cells stimulated by a female sex hormone called estrogen. Breast cancer may form in lobules (glands that produce milk), ducts of the breast (the pathway that brings milk from glands to the nipple), fatty tissue, or fibrous connective tissue within the breast. The tumour cells invade other healthy breast cells and travel to lymph nodes, a primary pathway for the cancer cells to move to other body parts. Symptoms of breast cancer include a lump in the breast or tissue thickening, which feels different than the normal surrounding tissues, breast pain, redness, swelling, and nipple discharge other than breast milk.

Stomach Cancer (gastric cancer): It is a type of cancer that develops from the stomach lining. Risk factors may include smoking, a highly processed or salty diet, and severe bacterial infection of H. pylori. Symptoms of stomach cancer include feeling bloated after eating, feeling full after eating small amounts of food, nausea, heartburn, or indigestion.

Pancreatic cancer: The malignant (cancer) cells form in the tissues of the pancreas. Signs and symptoms of pancreatic cancer include pain, diarrhoea, jaundice, and weight loss. Cigarette smoking is the major risk factor contributing to this type of cancer. 

Lung cancer: It happens when cells in the lung begin to grow in an uncontrolled manner. The most common form of lung cancer is non-small cell lung cancer (NSCLC). It happens when cells that form the lining of the lung start growing uncontrollably. Persons who smoke are at high risk of lung cancer. A common symptom of NSCLC is a cough that does not go easily, followed by shortness of breath. Cancerous lung cells spread off and travel through the bloodstream to distant regions of the body and grow.